Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q54123440)
Watch
English
The role of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection.
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9754886
retrieved
25 May 2018
reference URL
http://europepmc.org/abstract/MED/9754886
review article
1 reference
stated in
Europe PubMed Central
title
The role of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection.
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9754886
retrieved
25 May 2018
reference URL
http://europepmc.org/abstract/MED/9754886
main subject
HIV
0 references
author name string
E De Clercq
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9754886
retrieved
25 May 2018
reference URL
http://europepmc.org/abstract/MED/9754886
publication date
1 June 1998
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9754886
retrieved
25 May 2018
reference URL
http://europepmc.org/abstract/MED/9754886
published in
Antiviral Research
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9754886
retrieved
25 May 2018
reference URL
http://europepmc.org/abstract/MED/9754886
volume
38
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9754886
retrieved
25 May 2018
reference URL
http://europepmc.org/abstract/MED/9754886
issue
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9754886
retrieved
25 May 2018
reference URL
http://europepmc.org/abstract/MED/9754886
page(s)
153-179
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9754886
retrieved
25 May 2018
reference URL
http://europepmc.org/abstract/MED/9754886
cites work
The PETT series, a new class of potent nonnucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The benzylthio-pyrimidine U-31,355, a potent inhibitor of HIV-1 reverse transcriptase
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Potent and selective inhibition of human immunodeficiency virus type 1 (HIV-1) by 5-ethyl-6-phenylthiouracil derivatives through their interaction with the HIV-1 reverse transcriptase
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Preclinical evaluation of MKC-442, a highly potent and specific inhibitor of human immunodeficiency virus type 1 in vitro
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
2',5'-Bis-O-(tert-butyldimethylsilyl)-3'-spiro-5''-(4''-amino-1'',2''- oxathiole-2'',2'-dioxide)pyrimidine (TSAO) nucleoside analogues: highlyselective inhibitors of human immunodeficiency virus type 1 that are targeted at the viral reverse transcri
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
[2',5'-Bis-O-(tert-butyldimethylsilyl)]-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide) (TSAO) derivatives of purine and pyrimidinenucleosides as potent and selective inhibitors of human immunodeficiency virus type 1
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Knocking-out concentrations of HIV-1-specific inhibitors completely suppress HIV-1 infection and prevent the emergence of drug-resistant virus.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Resistance pattern of human immunodeficiency virus type 1 reverse transcriptase to quinoxaline S-2720
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Activity of various thiocarboxanilide derivatives against wild-type and several mutant human immunodeficiency virus type 1 strains.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Differential activities of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives against different human immunodeficiency virus type 1 mutant strains
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Suppression of the breakthrough of human immunodeficiency virus type 1 (HIV-1) in cell culture by thiocarboxanilide derivatives when used individually or in combination with other HIV-1-specific inhibitors (i.e., TSAO derivatives)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Concomitant combination therapy for HIV infection preferable over sequential therapy with 3TC and non-nucleoside reverse transcriptase inhibitors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Zidovudine-resistant human immunodeficiency virus type 1 strains subcultured in the presence of both lamivudine and quinoxaline HBY 097 retain marked sensitivity to HBY 097 but not to lamivudine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A novel mutation (F227L) arises in the reverse transcriptase of human immunodeficiency virus type 1 on dose-escalating treatment of HIV type 1-infected cell cultures with the nonnucleoside reverse transcriptase inhibitor thiocarboxanilide UC-781.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Retention of marked sensitivity to (S)-4-isopropoxycarbonyl-6-methoxy-3-(methylthiomethyl)-3,4-di hydroquin oxaline-2(1H)-thione (HBY 097) by an azidothymidine (AZT)-resistant human immunodeficiency virus type 1 (HIV-1) strain subcultured in the com
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
New arylpyrido-diazepine and -thiodiazepine derivatives are potent and highly selective HIV-1 inhibitors targeted at the reverse transcriptase
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Subunit specificity of mutations that confer resistance to nonnucleoside inhibitors in human immunodeficiency virus type 1 reverse transcriptase
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The inhibition of human immunodeficiency virus type 1 in vitro by a non-nucleoside reverse transcriptase inhibitor MKC-442, alone and in combination with other anti-HIV compounds
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Thiazolobenzimidazole: biological and biochemical anti-retroviral activity of a new nonnucleoside reverse transcriptase inhibitor
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Biological and biochemical anti-HIV activity of the benzothiadiazine class of nonnucleoside reverse transcriptase inhibitors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Resistance to 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives is generated by mutations at multiple sites in the HIV-1 reverse transcriptase
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Susceptibilities of human immunodeficiency virus type 1 enzyme and viral variants expressing multiple resistance-engendering amino acid substitutions to reserve transcriptase inhibitors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pyrrolobenzothiazepinones and pyrrolobenzoxazepinones: novel and specific non-nucleoside HIV-1 reverse transcriptase inhibitors with antiviral activity.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A controlled trial of nevirapine plus zidovudine versus zidovudine alone in p24 antigenaemic HIV-infected patients. The Dutch-Italian-Australian Nevirapine Study Group.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Bisheteroarylpiperazine reverse transcriptase inhibitor in combination with 3'-azido-3'-deoxythymidine or 2',3'-dideoxycytidine synergistically inhibits human immunodeficiency virus type 1 replication in vitro
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Serum levels of human immunodeficiency virus type 1 (HIV-1) RNA after seroconversion: a predictor of long-term mortality in HIV infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Nevirapine, zidovudine, and didanosine compared with zidovudine and didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group P
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Plasma viremia as a sensitive indicator of the antiretroviral activity of L-697,661.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized, controlled phase I/II, trial of combination therapy with delavirdine (U-90152S) and conventional nucleosides in human immunodeficiency virus type 1-infected patients.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
An antiviral target on reverse transcriptase of human immunodeficiency virus type 1 revealed by tetrahydroimidazo-[4,5,1-jk] [1,4]benzodiazepin-2 (1H)-one and -thione derivatives
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Non-nucleoside reverse transcriptase inhibitors (NNRTIs) for the treatment of human immunodeficiency virus type 1 (HIV-1) infections: strategies to overcome drug resistance development
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
What can be Expected from Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs) in the Treatment of Human Immunodeficiency Virus Type 1 (HIV-1) Infections?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High-dose nevirapine in previously untreated human immunodeficiency virus type 1-infected persons does not result in sustained suppression of viral replication
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacokinetics of R 82913 in AIDS patients: a phase I dose-finding study of oral administration compared with intravenous infusion
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Structure of HIV-1 reverse transcriptase in a complex with the non-nucleoside inhibitor alpha-APA R 95845 at 2.8 A resolution
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Structure of HIV-1 RT/TIBO R 86183 complex reveals similarity in the binding of diverse nonnucleoside inhibitors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
1,2,5-Benzothiadiazepine and pyrrolo[2,1-d]-[1,2,5]benzothiadiazepine derivatives with specific anti-human immunodeficiency virus type 1 activity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A new series of pyridinone derivatives as potent non-nucleoside human immunodeficiency virus type 1 specific reverse transcriptase inhibitors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
U-90152, a potent inhibitor of human immunodeficiency virus type 1 replication
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A mutation in reverse transcriptase of bis(heteroaryl)piperazine-resistant human immunodeficiency virus type 1 that confers increased sensitivity to other nonnucleoside inhibitors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
An extensively modified version of MolScript that includes greatly enhanced coloring capabilities
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mechanism of inhibition of HIV-1 reverse transcriptase by non-nucleoside inhibitors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Unique features in the structure of the complex between HIV-1 reverse transcriptase and the bis(heteroaryl)piperazine (BHAP) U-90152 explain resistance mutations for this nonnucleoside inhibitor
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Models which explain the inhibition of reverse transcriptase by HIV-1-specific (thio)carboxanilide derivatives.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pyridinone derivatives: specific human immunodeficiency virus type 1 reverse transcriptase inhibitors with antiviral activity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
L-696,229 specifically inhibits human immunodeficiency virus type 1 reverse transcriptase and possesses antiviral activity in vitro
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prophylaxis against HIV-1 infection in chimpanzees by nevirapine, a nonnucleoside inhibitor of reverse transcriptase.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Viral dynamics of HIV: implications for drug development and therapeutic strategies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High-dose nevirapine: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A Pilot Study to Evaluate the Development of Resistance to Nevirapine in Asymptomatic Human Immunodeficiency Virus-Infected Patients with CD4 Cell Counts of >500/mm3 : AIDS Clinical Trials Group Protocol 208
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Potent and specific inhibition of human immunodeficiency virus type 1 replication by 4-(2,6-dichlorophenyl)-1,2,5-thiadiazol-3-Y1 N,N-dialkylcarbamate derivatives
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Anti-HIV-1 activity of thiadiazole derivatives: structure-activity relationship, reverse transcriptase inhibition, and lipophilicity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Synergistic inhibition of human immunodeficiency virus type 1 (HIV-1) replication in vitro by 1-[(2-hydroxyethoxy)methyl]-6-phenylthiothymine (HEPT) and recombinant alpha interferon
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Novel non-nucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase. 6. 2-Indol-3-yl- and 2-azaindol-3-yl-dipyridodiazepinones
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Synthesis and anti-HIV-1 activity of a series of 1-alkoxy-5-alkyl-6-(arylthio)uracils
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Activity of a novel quinoxaline derivative against human immunodeficiency virus type 1 reverse transcriptase and viral replication
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mutational analysis of residue 190 of human immunodeficiency virus type 1 reverse transcriptase
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Preclinical evaluation of HBY 097, a new nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1 replication
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Q28378760
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
In vitro selection for different mutational patterns in the HIV-1 reverse transcriptase using high and low selective pressure of the nonnucleoside reverse transcriptase inhibitor HBY 097.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by the dipyridodiazepinone BI-RG-587
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Molecular modeling studies of HIV-1 reverse transcriptase nonnucleoside inhibitors: total energy of complexation as a predictor of drug placement and activity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
3'-Azido-3'-deoxythymidine resistance suppressed by a mutation conferring human immunodeficiency virus type 1 resistance to nonnucleoside reverse transcriptase inhibitors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Synthesis and anti-HIV-1 activity of a series of imidazo[1,5-b]pyridazines
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combination treatment with zidovudine, didanosine, and nevirapine in infants with human immunodeficiency virus type 1 infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Viral resistance to the thiazolo-iso-indolinones, a new class of nonnucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Use of changes in plasma levels of human immunodeficiency virus type 1 RNA to assess the clinical benefit of antiretroviral therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prognosis in HIV-1 infection predicted by the quantity of virus in plasma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Inhibition of HIV-1 Replication by a Nonnucleoside Reverse Transcriptase Inhibitor
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Selective non-nucleoside HIV-1 reverse transcriptase inhibitors. New 2,3-dihydrothiazolo[2,3-a]isoindol-5(9bH)-ones and related compounds with anti-HIV-1 activity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A novel lead for specific anti-HIV-1 agents: 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Complete inhibition of viral breakthrough by combination of MKC-442 with AZT during a long-term culture of HIV-1 infected cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
In vitro inhibition of human immunodeficiency virus type 1 by a combination of delavirdine (U-90152) with protease inhibitor U-75875 or interferon-alpha
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Studies in subjects with long-term nonprogressive human immunodeficiency virus infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Potent and highly selective human immunodeficiency virus type 1 (HIV-1) inhibition by a series of alpha-anilinophenylacetamide derivatives targeted at HIV-1 reverse transcriptase
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
New tetrahydroimidazo[4,5,1-jk][1,4]-benzodiazepin-2(1H)-one and -thione derivatives are potent inhibitors of human immunodeficiency virus type 1 replication and are synergistic with 2',3'-dideoxynucleoside analogs
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacokinetics of R 82913 in patients with AIDS or AIDS-related complex
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High resolution structures of HIV-1 RT from four RT-inhibitor complexes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The structure of HIV-1 reverse transcriptase complexed with 9-chloro-TIBO: lessons for inhibitor design
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
BI-RG-587 is active against zidovudine-resistant human immunodeficiency virus type 1 and synergistic with zidovudine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Nonnucleoside reverse transcriptase inhibitors that potently and specifically block human immunodeficiency virus type 1 replication
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Q28297986
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Second-generation non-nucleosidic reverse transcriptase inhibitor HBY097 and HIV-1 viral load
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A short-term clinical evaluation of L-697,661, a non-nucleoside inhibitor of HIV-1 reverse transcriptase. L-697,661 Working Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
HIV viral load markers in clinical practice
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase 1 study of combination therapy with L-697,661 and zidovudine. The ACTG 184 Protocol Team
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Synthesis and biological evaluation of 5H-indolo [3,2-b][1,5]benzothiazepine derivatives, designed as conformationally constrained analogues of the human immunodeficiency virus type 1 reverse transcriptase inhibitor L-737,126.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mechanism of inhibition of HIV-1 reverse transcriptase by nonnucleoside inhibitors.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combination therapy with zidovudine prevents selection of human immunodeficiency virus type 1 variants expressing high-level resistance to L-697,661, a nonnucleoside reverse transcriptase inhibitor
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Virological and immunological analysis of a triple combination pilot study with loviride, lamivudine and zidovudine in HIV-1-infected patients.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Locations of anti-AIDS drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase. Implications for mechanisms of drug inhibition and resistance
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Synthesis of a series of 4-(arylethynyl)-6-chloro-4-cyclopropyl-3,4-dihydroquinazolin-2(1H)-ones as novel non-nucleoside HIV-1 reverse transcriptase inhibitors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prevention of the spread of HIV-1 infection with nonnucleoside reverse transcriptase inhibitors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Enhanced fidelity of 3TC-selected mutant HIV-1 reverse transcriptase
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Viral dynamics in human immunodeficiency virus type 1 infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
5-chloro-3-(phenylsulfonyl)indole-2-carboxamide: a novel, non-nucleoside inhibitor of HIV-1 reverse transcriptase
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Selection conditions affect the evolution of specific mutations in the reverse transcriptase gene associated with resistance to DMP 266.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Recovery of replication-competent HIV despite prolonged suppression of plasma viremia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
L-743, 726 (DMP-266): a novel, highly potent nonnucleoside inhibitor of the human immunodeficiency virus type 1 reverse transcriptase
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Structural analogues of the calanolide anti-HIV agents. Modification of the trans-10,11-dimethyldihydropyran-12-ol ring (ring C).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Inhibition of human immunodeficiency virus type 1 wild-type and mutant reverse transcriptases by the phenyl ethyl thiazolyl thiourea derivatives trovirdine and MSC-127.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900025-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0166-3542(98)00025-4
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9754886
retrieved
25 May 2018
reference URL
http://europepmc.org/abstract/MED/9754886
PubMed publication ID
9754886
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9754886
retrieved
25 May 2018
reference URL
http://europepmc.org/abstract/MED/9754886
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit